| Product NDC: | 42769-1225 |
| Proprietary Name: | Fluvoxamine Maleate |
| Non Proprietary Name: | Fluvoxamine Maleate |
| Active Ingredient(s): | 50 mg/1 & nbsp; Fluvoxamine Maleate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42769-1225 |
| Labeler Name: | BayPharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021519 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080125 |
| Package NDC: | 42769-1225-0 |
| Package Description: | 100 TABLET in 1 BOTTLE (42769-1225-0) |
| NDC Code | 42769-1225-0 |
| Proprietary Name | Fluvoxamine Maleate |
| Package Description | 100 TABLET in 1 BOTTLE (42769-1225-0) |
| Product NDC | 42769-1225 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluvoxamine Maleate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080125 |
| Marketing Category Name | NDA |
| Labeler Name | BayPharma, Inc. |
| Substance Name | FLUVOXAMINE MALEATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |